Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2020 1
2021 7
2023 2
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

11 results

Results by year

Filters applied: . Clear all
Page 1
Activity and safety of first-line treatments for advanced melanoma: A network meta-analysis.
Boutros A, Tanda ET, Croce E, Catalano F, Ceppi M, Bruzzone M, Cecchi F, Arecco L, Fraguglia M, Pronzato P, Genova C, Del Mastro L, Lambertini M, Spagnolo F. Boutros A, et al. Among authors: croce e. Eur J Cancer. 2023 Jul;188:64-79. doi: 10.1016/j.ejca.2023.04.010. Epub 2023 Apr 24. Eur J Cancer. 2023. PMID: 37196485 Free article. Review.
Merkel Cell Carcinoma: An Immunotherapy Fairy-Tale?
Tanda ET, d'Amato AL, Rossi G, Croce E, Boutros A, Cecchi F, Spagnolo F, Queirolo P. Tanda ET, et al. Among authors: croce e. Front Oncol. 2021 Sep 23;11:739006. doi: 10.3389/fonc.2021.739006. eCollection 2021. Front Oncol. 2021. PMID: 34631574 Free PMC article. Review.
The treatment of advanced melanoma: Current approaches and new challenges.
Boutros A, Croce E, Ferrari M, Gili R, Massaro G, Marconcini R, Arecco L, Tanda ET, Spagnolo F. Boutros A, et al. Among authors: croce e. Crit Rev Oncol Hematol. 2024 Apr;196:104276. doi: 10.1016/j.critrevonc.2024.104276. Epub 2024 Jan 29. Crit Rev Oncol Hematol. 2024. PMID: 38295889 Free article. Review.
Immunotherapy for the Treatment of Cutaneous Squamous Cell Carcinoma.
Boutros A, Cecchi F, Tanda ET, Croce E, Gili R, Arecco L, Spagnolo F, Queirolo P. Boutros A, et al. Among authors: croce e. Front Oncol. 2021 Aug 26;11:733917. doi: 10.3389/fonc.2021.733917. eCollection 2021. Front Oncol. 2021. PMID: 34513710 Free PMC article. Review.
How to Make Immunotherapy an Effective Therapeutic Choice for Uveal Melanoma.
Marseglia M, Amaro A, Solari N, Gangemi R, Croce E, Tanda ET, Spagnolo F, Filaci G, Pfeffer U, Croce M. Marseglia M, et al. Among authors: croce e. Cancers (Basel). 2021 Apr 23;13(9):2043. doi: 10.3390/cancers13092043. Cancers (Basel). 2021. PMID: 33922591 Free PMC article. Review.
Neoadjuvant treatments in patients with high-risk resectable stage III/IV melanoma.
Spagnolo F, Croce E, Boutros A, Tanda E, Cecchi F, Mascherini M, Solari N, Cafiero F, Queirolo P. Spagnolo F, et al. Among authors: croce e. Expert Rev Anticancer Ther. 2020 May;20(5):403-413. doi: 10.1080/14737140.2020.1760847. Epub 2020 May 3. Expert Rev Anticancer Ther. 2020. PMID: 32326767 Review.
11 results